Core Viewpoint - The company, Zhongjie Automotive, focuses on the research, production, and sales of automotive thermal management system components, aiming to become a specialized supplier with technological extensibility [1] Group 1: Business Focus - The company is a precision manufacturing enterprise centered on automotive thermal management system components [1] - It leverages its mature technology and precision manufacturing capabilities in the heat exchange field to expand its core business [1] Group 2: Future Strategy - The company plans to continue deepening its main business while cautiously exploring diversification opportunities related to its core capabilities [1] - The goal is to establish itself as a professional supplier with technological extensibility [1]

Core Viewpoint - The company expresses confidence in its stable operations and growth prospects for 2025, highlighting a focus on emerging markets and specific business areas [1] Financial Performance - In the first three quarters, the company achieved total revenue of 809 million yuan, representing a year-on-year growth of 11.68% [1] Business Strategy - The company is actively expanding into emerging markets while continuing to focus on the development of automotive thermal management systems and new business areas [1]

关于注销部分募集资金专项账户的公告 证券代码：301560 证券简称：众捷汽车 公告编号：2026-001 苏州众捷汽车零部件股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 经中国证券监督管理委员会于 2025 年 2 月 18 日出具的《关于同意 苏州众捷汽车零部件股份有限公司首次公开发行股票注册的批复》（证 监许可[2025]309 号）同意，苏州众捷汽车零部件股份有限公司（以下 简称"公司"）首次向社会公开发行人民币普通股（A 股）3,040.00 万股，每股发行价格 16.50 元，新股发行募集资金总额为 50,160.00 万元，扣除各项发行费用后，募集资金净额为 42,316.09 万元。容诚会 计师事务所（特殊普通合伙）对公司首次公开发行股票的资金到位情况 进行了审验，并出具了"容诚验字[2025]230Z0036 号"《验资报告》。 二、募集资金存放和管理情况 为规范公司募集资金管理和使用，保护投资者利益，公司根据有关 法律法规和规范性文件的规定，并结合实际情况，制定了《募集资金管 理制度》，对募集资金实行专 ...

Core Viewpoint - The company has successfully expanded its collaboration with Boyd Corporation, a leader in thermal management solutions, becoming a supplier of precision machining components for data center liquid cooling products in North America and Europe [2] Group 1: Company Collaboration - The company leverages its core capabilities in precision machining to establish a partnership with Boyd Corporation [2] - The collaboration involves supplying components for data center liquid cooling applications [2] - The end users of the liquid cooling products are confidential and cannot be disclosed [2]

Group 1 - On December 30, Zhongjie Automotive's stock fell by 0.20%, with a trading volume of 29.99 million yuan [1] - The financing data on the same day showed a financing purchase amount of 2.51 million yuan and a financing repayment of 3.20 million yuan, resulting in a net financing outflow of 0.69 million yuan [1] - As of December 30, the total balance of margin trading for Zhongjie Automotive was 64.63 million yuan, with a financing balance of 64.42 million yuan, accounting for 7.73% of the circulating market value [1] Group 2 - As of December 10, the number of shareholders for Zhongjie Automotive was 9,931, a decrease of 2.65% from the previous period [2] - For the period from January to September 2025, Zhongjie Automotive achieved an operating income of 809 million yuan, representing a year-on-year growth of 11.68%, while the net profit attributable to the parent company was 61.35 million yuan, a decrease of 9.46% year-on-year [2] - Since its A-share listing, Zhongjie Automotive has distributed a total of 9.73 million yuan in dividends [2]

Group 1 - The company, Suzhou Zhongjie Automotive Parts Co., Ltd., has received a project confirmation letter from a leading global customer in the automotive thermal management system sector for a new electric air conditioning compressor project, with expected sales of approximately $29.86 million over its lifecycle [1] - The company plans to begin mass supply to the customer's North American electric air conditioning compressor assembly plant in early 2026, indicating a significant step in its international expansion [1] - This project is seen as a recognition of the company's R&D advantages and lean manufacturing capabilities in the automotive thermal management field, enhancing its competitiveness and profitability in the international market [1]

Group 1 - The company received a project confirmation letter for a new electric air conditioning compressor from a leading global automotive thermal management system client, with expected sales of approximately $29.86 million over the product lifecycle [1] - The project is set to begin mass production in early 2026 at the company's assembly plant in North America, enhancing its international market competitiveness and profitability [1] - The company has established a strong R&D advantage and lean manufacturing capability in the automotive thermal management sector, which has been recognized by the international client [1] Group 2 - The company specializes in the R&D, production, and sales of precision components for automotive thermal management systems, including air conditioning heat exchangers, oil coolers, heat pump systems, and battery coolers, primarily using aluminum alloy products [2] - The company has accumulated extensive experience in the production of thermal management system components and possesses strong capabilities in precision component design, collaborative development, and production [2] - The company is closely following the trends of electrification and intelligence in the automotive industry, with advanced core technologies in smart manufacturing, flexible production, precision processing, and digital management [2] Group 3 - The company has successfully expanded its collaboration with Boyd Corporation, a leader in thermal management solutions, supplying precision components for data center liquid cooling in North America and Europe [3] - Future growth is expected to depend on the release of new energy vehicles and emerging business opportunities, along with effective cost control measures [3] - The company aims to solidify its competitiveness through technological upgrades, cost reduction, and the expansion of emerging businesses [3]

Group 1 - Shareholder of Okoyi plans to reduce holdings by up to 1.89% of the company's shares, amounting to a maximum of 3 million shares due to personal funding needs [1] - Tianchuang Fashion is planning a change in control, leading to continued suspension of its stock trading, expected to last no more than 3 trading days [2] - China Electric Power Construction Company reported a new contract amount of 10,317.55 billion yuan for the first 11 months of 2025, a year-on-year decrease of 1.65% [3] Group 2 - Pilin Bio's wholly-owned subsidiary received approval for a clinical trial of a drug, indicating progress in its product development [4] - Yihong Medical obtained two medical device registration certificates for diagnostic kits, enhancing its product portfolio [5] - Aohong Electronics plans to use up to 450 million yuan of idle fundraising for cash management, targeting safe and liquid financial products [6] Group 3 - China Electric Power Construction signed a contract worth approximately 6.626 billion yuan for a natural gas booster station project in Turkey, with a construction period of about 55 months [7] - Baosheng Co. won a bid for a power cable project in Singapore, valued at around 1.2 billion yuan, marking the largest overseas order in its history [8] - *ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase plan that will raise its total share capital to 3.29 billion shares [9] Group 4 - Ningbo Construction's subsidiary signed a construction contract worth 428 million yuan for an engineering project with a duration of 990 days [11] - Lianhuan Pharmaceutical's subsidiary received approval for a drug that passed the consistency evaluation for generic drugs, enhancing its market competitiveness [12] - Zhongjie Automotive received a project designation for a new electric air conditioning compressor, with expected sales of approximately 29.86 million USD over its lifecycle [13] Group 5 - Biopharmaceuticals' major shareholder plans to increase holdings by 50 million to 100 million yuan, indicating confidence in the company's future [14] - Haizheng Pharmaceutical's subsidiary received approval for a veterinary drug product, expanding its product offerings in the animal health sector [15] - *ST Songfa's subsidiary signed contracts for the construction of 8 vessels, with a total contract value between 200 million to 400 million USD [16] Group 6 - Shandong Pharmaceutical Glass announced the resignation of its chairman due to age reasons, indicating a potential leadership transition [17] - Xinno Wei's subsidiary received approval for a clinical trial of a monoclonal antibody drug, indicating advancements in its drug development pipeline [18] - Ningbo Huaxiang's subsidiary secured an order for robot joints, expected to positively impact future business performance [19][20] Group 7 - China Resources Double Crane's subsidiary received approval for a clinical trial of a drug aimed at treating a genetic eye disease, reflecting ongoing R&D efforts [21] - Huaxin Technology's shareholders set a transfer price of 56.69 yuan per share for a block of shares, indicating active shareholder engagement [22] - Xinhua Net announced the resignation of its president due to job relocation, suggesting potential changes in management [23] Group 8 - Taiji Group plans to transfer a 40% stake in a subsidiary to focus on its core pharmaceutical business, enhancing operational efficiency [24] - Huaxin Construction's shareholder plans to increase holdings by 200 million to 400 million yuan, reflecting confidence in the company's prospects [25] - Dongjie Intelligent is planning to issue shares and cash for asset acquisition, with stock trading suspended until further notice [26] Group 9 - Wanrun New Energy was designated as a delivery warehouse for lithium carbonate futures, indicating its strategic position in the market [27] - Prolo Pharmaceutical's subsidiary received a drug registration certificate for an influenza treatment, expanding its product range [28] - Saiwu Technology invested 5 million yuan in a private equity fund focused on smart vehicles and energy innovation, indicating strategic investment in growth sectors [29] Group 10 - Bohui Innovation's subsidiary received approval for a clinical trial of an immunoglobulin drug, indicating progress in its product development [30] - Bohui Innovation's subsidiary also received a drug registration certificate for a coagulation factor product, enhancing its therapeutic offerings [31] - Hanghua Co. plans to allocate 146 million yuan of surplus fundraising for a new green printing materials project, reflecting a commitment to sustainability [32] Group 11 - Nova Star Cloud obtained a loan commitment letter from a bank for a share repurchase plan, indicating financial support for its capital management strategy [33] - Jimin Health established a joint venture for technology innovation, indicating a strategic move to enhance its technological capabilities [34] - Huili Pharmaceutical received a drug registration certificate for a medication used in treating digestive ulcers, expanding its product portfolio [35]

Core Viewpoint - The company has received a project confirmation letter for a new electric air conditioning compressor scroll from a leading global automotive thermal management system client, indicating a significant business opportunity in the electric vehicle sector [1] Group 1: Project Details - The company is expected to begin mass supply of electric air conditioning compressors to its assembly plant in North America starting in early 2026 [1] - The projected sales revenue over the lifecycle of the project is approximately $29.86 million [1]

Core Viewpoint - The company, Zhongjie Automotive, has received a project confirmation letter for a new electric air conditioning compressor scroll from a leading global automotive thermal management system client, indicating a significant business opportunity in the electric vehicle sector [1] Group 1: Project Details - The company is expected to begin mass supply of electric air conditioning compressors to the client's assembly plant in North America starting in early 2026 [1] - The projected sales revenue over the lifecycle of the project is approximately $29.86 million [1]